Instrument Inactif

Communiqués BioTime, Inc. Nyse

Actions

Cours en clôture Nyse Autres places de cotation
- ^USD	-

21/05	Lineage Cell Therapeutics, Inc. annonce la mise à jour du 2e symposium annuel des investisseurs sur les lésions de la moelle épinière	CI
09/05	Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Lineage to Present at 2024 BIO International Convention	30/05	BU
Lineage Cell Therapeutics : FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP CULLEY BRAIN M	29/05	PU
Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium	21/05	BU
Lineage Cell Therapeutics : Opinion of Sheppard Mullin Richter & Hampton, LLP relating to the legality of the ATM Shares	21/05	PU
Lineage Cell Therapeutics : Prospectus disclosing information, facts, events	21/05	PU
Lineage Cell Therapeutics : Immediate Report	11/05	PU
Lineage Cell: Q1 Earnings Snapshot	09/05	AQ
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	09/05	BU
LINEAGE CELL - OPREGEN PHASE 1/2A CLINICAL STUDY 24-MONTH VISUAL ACUITY RESULTS FEATURED AT 2024 RETINAL CELL AND GENE THERAPY INNOVATION SUMMIT	07/05	AQ
OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit	06/05	BU
Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024	02/05	BU
LINEAGE RECEIVES GRANT FROM CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE	01/05	AQ
Lineage Cell Therapeutics : Immediate Report	30/04	PU
Lineage Cell Therapeutics : Additional proxy soliciting materials - definitive	30/04	PU
Lineage Cell Therapeutics : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 11, 2024, PROXY	30/04	PU
Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)	30/04	BU
Lineage Announces Changes to Board of Directors	29/04	BU
Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development	01/04	BU
Lineage Cell Therapeutics : Immediate Report	24/03	PU
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium	18/03	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Découvrez nos Contenus Gratuits pour vous Aider à Mieux Comprendre les Marchés Boursiers.

Inscription 100% Gratuite

fermer